Full Text Journal Articles from
Abstract 30804341

Advertisement

Find full text journal articles








Disturbed homocysteine metabolism is associated with cancer.

PMID: 30804341 (view PubMed database entry)
DOI: 10.1038/s12276-019-0216-4 (read at publisher's website )
PMCID: PMC6389897 (free full text version available)

Download PDF Download PDF

Tauheed Hasan, Reetika Arora, Aniket Kumar Bansal, Reshmee Bhattacharya, Gurumayum Suraj Sharma, Laishram Rajendrakumar Singh,

Dr. B. R. Ambedkar Center for Biomedical Research, University of Delhi, Delhi, 110 007, India. [email protected]

Hyperhomocysteinemia/Homocysteinuria is characterized by an increased level of toxic homocysteine in the plasma. The plasma concentration of homocysteine is 5-15 μmol/L in healthy individuals, while in hyperhomocysteinemic patients, it can be as high as 500 μmol/L. While increased homocysteine levels can cause symptoms such as osteoporosis and eye lens dislocation, high homocysteine levels are most closely associated with cardiovascular complications. Recent advances have shown that increased plasma Hcy is also a fundamental cause of neurodegenerative diseases (including Alzheimer's disease, Parkinson's disease, and dementia), diabetes, Down syndrome, and megaloblastic anemia, among others. In recent years, increased plasma homocysteine has also been shown to be closely related to cancer. In this review, we discuss the relation between elevated plasma Hcy levels and cancer, and we conclude that disturbed homocysteine metabolism is associated with cancer. Future clinical perspectives are also discussed.

Exp. Mol. Med. (Experimental & molecular medicine)
[2019, 51(2):1-13]

Cited: 0 times

AltMetric Statistics
Authors' Affiliation
Map for Author Affiliation





Advertisement

Disclaimer
0.6908 s